OHI Quote, Financials, Valuation and Earnings

National Health Investors has a net margin of 39.39% compared to Omega Healthcare Investors's net margin of 50.43%. Omega Healthcare Investors's return on equity of 10.34% beat National Health Investors's return on equity of 10.72%.

Omega Healthcare Investors has a consensus price target of $40.80, signalling upside risk potential of 10.21%. On the other hand National Health Investors has an analysts' consensus of $80.86 which suggests that it could grow by 6.57%. Given that Omega Healthcare Investors has higher upside potential than National Health Investors, analysts believe Omega Healthcare Investors is more attractive than National Health Investors.

Omega Healthcare Investors has a beta of 0.731, which suggesting that the stock is 26.872% less volatile than S&P 500. In comparison National Health Investors has a beta of 0.776, suggesting its less volatile than the S&P 500 by 22.371%.

Omega Healthcare Investors has a quarterly dividend of $0.67 per share corresponding to a yield of 7.24%. National Health Investors offers a yield of 4.75% to investors and pays a quarterly dividend of $0.90 per share. Omega Healthcare Investors pays 168.69% of its earnings as a dividend. National Health Investors pays out 113.43% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Omega Healthcare Investors quarterly revenues are $276.8M, which are larger than National Health Investors quarterly revenues of $85.8M. Omega Healthcare Investors's net income of $109M is higher than National Health Investors's net income of $43.2M. Notably, Omega Healthcare Investors's price-to-earnings ratio is 22.99x while National Health Investors's PE ratio is 24.32x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Omega Healthcare Investors is 9.55x versus 9.98x for National Health Investors. Usually stocks with elevated PS ratios are considered overvalued.

Prologis has a net margin of 39.39% compared to Omega Healthcare Investors's net margin of 27.71%. Omega Healthcare Investors's return on equity of 10.34% beat Prologis's return on equity of 6.45%.

Omega Healthcare Investors has a consensus price target of $40.80, signalling upside risk potential of 10.21%. On the other hand Prologis has an analysts' consensus of $118.55 which suggests that it could grow by 12.47%. Given that Prologis has higher upside potential than Omega Healthcare Investors, analysts believe Prologis is more attractive than Omega Healthcare Investors.

Omega Healthcare Investors has a beta of 0.731, which suggesting that the stock is 26.872% less volatile than S&P 500. In comparison Prologis has a beta of 1.251, suggesting its more volatile than the S&P 500 by 25.051%.

Omega Healthcare Investors has a quarterly dividend of $0.67 per share corresponding to a yield of 7.24%. Prologis offers a yield of 3.69% to investors and pays a quarterly dividend of $1.01 per share. Omega Healthcare Investors pays 168.69% of its earnings as a dividend. Prologis pays out 95.68% of its earnings as a dividend. Prologis's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Omega Healthcare Investors's is not.

Omega Healthcare Investors quarterly revenues are $276.8M, which are smaller than Prologis quarterly revenues of $2.1B. Omega Healthcare Investors's net income of $109M is lower than Prologis's net income of $593M. Notably, Omega Healthcare Investors's price-to-earnings ratio is 22.99x while Prologis's PE ratio is 26.29x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Omega Healthcare Investors is 9.55x versus 12.00x for Prologis. Usually stocks with elevated PS ratios are considered overvalued.

Tanger has a net margin of 39.39% compared to Omega Healthcare Investors's net margin of 14.19%. Omega Healthcare Investors's return on equity of 10.34% beat Tanger's return on equity of 15.44%.

Omega Healthcare Investors has a consensus price target of $40.80, signalling upside risk potential of 10.21%. On the other hand Tanger has an analysts' consensus of $37.89 which suggests that it could grow by 26.97%. Given that Tanger has higher upside potential than Omega Healthcare Investors, analysts believe Tanger is more attractive than Omega Healthcare Investors.

Omega Healthcare Investors has a beta of 0.731, which suggesting that the stock is 26.872% less volatile than S&P 500. In comparison Tanger has a beta of 1.181, suggesting its more volatile than the S&P 500 by 18.101%.

Omega Healthcare Investors has a quarterly dividend of $0.67 per share corresponding to a yield of 7.24%. Tanger offers a yield of 3.75% to investors and pays a quarterly dividend of $0.29 per share. Omega Healthcare Investors pays 168.69% of its earnings as a dividend. Tanger pays out 121.95% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Omega Healthcare Investors quarterly revenues are $276.8M, which are larger than Tanger quarterly revenues of $135.4M. Omega Healthcare Investors's net income of $109M is higher than Tanger's net income of $19.2M. Notably, Omega Healthcare Investors's price-to-earnings ratio is 22.99x while Tanger's PE ratio is 35.52x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Omega Healthcare Investors is 9.55x versus 6.21x for Tanger. Usually stocks with elevated PS ratios are considered overvalued.

Welltower has a net margin of 39.39% compared to Omega Healthcare Investors's net margin of 5.41%. Omega Healthcare Investors's return on equity of 10.34% beat Welltower's return on equity of 3.21%.

Omega Healthcare Investors has a consensus price target of $40.80, signalling upside risk potential of 10.21%. On the other hand Welltower has an analysts' consensus of $165.45 which suggests that it could grow by 9.61%. Given that Omega Healthcare Investors has higher upside potential than Welltower, analysts believe Omega Healthcare Investors is more attractive than Welltower.

Omega Healthcare Investors has a beta of 0.731, which suggesting that the stock is 26.872% less volatile than S&P 500. In comparison Welltower has a beta of 0.943, suggesting its less volatile than the S&P 500 by 5.67%.

Omega Healthcare Investors has a quarterly dividend of $0.67 per share corresponding to a yield of 7.24%. Welltower offers a yield of 1.74% to investors and pays a quarterly dividend of $0.67 per share. Omega Healthcare Investors pays 168.69% of its earnings as a dividend. Welltower pays out 162.37% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Omega Healthcare Investors quarterly revenues are $276.8M, which are smaller than Welltower quarterly revenues of $2.2B. Omega Healthcare Investors's net income of $109M is lower than Welltower's net income of $120M. Notably, Omega Healthcare Investors's price-to-earnings ratio is 22.99x while Welltower's PE ratio is 96.62x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Omega Healthcare Investors is 9.55x versus 11.68x for Welltower. Usually stocks with elevated PS ratios are considered overvalued.